• Mashup Score: 1

    Euglycemic diabetic ketoacidosis (DKA) is relatively uncommon, but its incidence seems to be increasing. Sodium–glucose cotransporter-2 (SGLT-2)

    Tweet Tweets with this article
    • Rise in Euglycemic DKA Might Be Associated with SGLT-2 Inhibitor Use Diabetic ketoacidosis diagnosis was delayed and duration of DKA was longer in patients with euglycemic DKA. https://t.co/bpOdN2DiLc #diabetes @DresslerDD https://t.co/28BAa3A1pO

  • Mashup Score: 11

    The Neuropathic Pain Special Interest Group, part of the International Association for the Study of Pain, conducted a systematic review and

    Tweet Tweets with this article
    • Pharmacologic Management of Neuropathic Pain Updated recommendations based on a meta-analysis from an international group of pain specialists. https://t.co/Rf3Kiyx0uc #NeuropathicPain #MedTwitter https://t.co/Jnl6acrwTZ

  • Mashup Score: 13

    Sponsoring Organization: Centers for Disease ControlBackground and ObjectiveThe CDC last issued guidelines for nonoccupational postexposure prophylaxis

    Tweet Tweets with this article
    • In new CDC guidelines for HIV nonoccupational postexposure prophylaxis, integrase inhibitor–based regimens are recommended for 28 days after nonoccupational exposures. https://t.co/x4fTzMnTJ8 #IDTwitter #HIV #guidelines @RMKGandhi https://t.co/1Y45Q2Sc5M

  • Mashup Score: 78

    To delay progression of diabetic kidney disease, guidelines recommend 3 drug classes for selected patients: (1) renin–angiotensin system inhibitors,

    Tweet Tweets with this article
    • To delay progression of diabetic kidney disease, guidelines recommend 3 drug classes for selected patients: renin–angiotensin system inhibitors, SGLT-2 inhibitors, and finerenone. A new study provides data on simultaneous use of all 3. https://t.co/6Q9dhUlQ6F @NEJM #diabetes https://t.co/nlCDRA3DNB